Standby Emergency Treatment of Malaria in Travelers

Experience to Date and New Developments

Patricia Schlagenhauf; Eskild Petersen

Disclosures

Expert Rev Anti Infect Ther. 2012;10(5):537-546. 

In This Article

Counterfeit Medication

The issue of counterfeit medication is of great importance and carriage of an SBET bought prior to travel ensures reliable quality of medication in contrast to locally bought medication that could be counterfeit.[34] Counterfeits of most antimalarials have been reported, and the situation is particularly acute with regard to oral artemisinins in Asia where it is estimated that more than 50% of available products are fake.[34] Counterfeit artemisinin products have also been reported in Africa.[35] Use of fake or substandard products by travelers for the treatment of a disease with a high mortality in untreated falciparum malaria should be avoided at all costs. There is little information available to travelers and their physicians in their home country or their destination about problems with drug quality. The frequency with which travelers have knowledge of the dangers of fake medication is difficult to gauge.[36] Carriage of a quality antimalarial treatment for use under medical supervision would circumvent the need to buy local, possibly counterfeit medication.

Comments

3090D553-9492-4563-8681-AD288FA52ACE
Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as:

processing....